Proflazepam
Appearance
From Wikipedia, the free encyclopedia
This is the current revision of this page, as edited by Buidhe (talk | contribs) at 07:39, 7 December 2023 (Removing from Category:GABAA receptor positive allosteric modulators in subcat using Cat-a-lot). The present address (URL) is a permanent link to this version.
Revision as of 07:39, 7 December 2023 by Buidhe (talk | contribs) (Removing from Category:GABAA receptor positive allosteric modulators in subcat using Cat-a-lot)
(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Chemical compound
![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C18H16ClFN2O3 |
Molar mass | 362.79 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Proflazepam (Ro10-3580) is a drug which is a benzodiazepine derivative.[1]
See also
[edit]References
[edit]- ^ "LIST OF INTERNATIONAL NON-PROPRIETARY NAMES (INNS), PROVIDED FOR PHARMACEUTICAL SUBSTANCES BY THE WORLD HEALTH ORGANIZATION, WHICH ARE FREE OF DUTY" (PDF). Official Journal of the European Communities. eur-lex.europa.eu. 23 October 2001. Retrieved 7 December 2009.
Hidden categories:
- Articles with short description
- Short description matches Wikidata
- Articles with changed ChemSpider identifier
- Articles with changed InChI identifier
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs missing an ATC code
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- All stub articles